UK MHRA approves trofolastat for diagnostic imaging of prostate cancer in men: United Kingdom Monday, March 31, 2025, 15:00 Hrs [IST] The Medicines and Healthcare products Regulat ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory ...

Seven new CERSIs came together to showcase how partnerships will modernise regulation in AI, clinical trials, and advanced therapies, bringing ...

The Clarkson's Farm star shared some of the negative side effects he experienced while taking Ozempic for weight loss.

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...

OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today provided a regulatory update for its ...

Manufactured in India the drug is sold over the counter in various countries as an erectile dysfunction drug, including ...

England’s patient safety commissioner has warned that patients with vision or hearing impairments are at greater risk from medicines and medical devices because their views are not sufficiently ...

Reneural has been awarded funding from NHS England to develop its virtual reality stroke rehabilitation platform for patients ...

Dame June Raine is leaving the civil service today after four decades at the Medicines and Healthcare Products Regulatory ...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...